CJC-1295 No DAC
10 mg
Modified GHRH (1–29) analog without albumin binding, used as a short-duration receptor reference.
$139.99
DetailsHover to zoom
Growth Hormone ResearchSynthetic research compound
Ipamorelin / Tesamorelin
$69.99
5/5 mgThis preparation pairs ipamorelin, a selective growth hormone secretagogue receptor agonist, with tesamorelin, a protease-resistant GHRH analog, in an ipamorelin-forward ratio.
It is used in laboratory work where the secretagogue receptor is the primary variable of interest and GHRH receptor activity is present as a supporting condition.
Research areas
Ghrelin receptor activityGHRH receptor signalingSecretagogue pathway researchPreclinical research
Form: Lyophilized (freeze-dried)
- Compound class
- Synthetic research compound
- Research category
- Growth Hormone Research
- SKU
- NVR-IPAMORELIN-TESAMORELIN-5-5MG
- Appearance
- Lyophilized powder
- Storage
- Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Strength
5/5 mg$69.99$7.00/mg
1
$69.99per 5/5 mg$7.00/mg
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know
More detail on Ipamorelin / Tesamorelin.
Analytical values reflect per-lot documentation and appear once a batch is released.
Compound
Ratio matters in combined-agonist research. This preparation weights the secretagogue component more heavily, which suits experimental designs focused on growth hormone secretagogue receptor pharmacology while retaining GHRH receptor input in the background. Ipamorelin is valued in the literature for its selectivity relative to earlier secretagogue peptides, and tesamorelin contributes stability at the GHRH receptor. Investigators comparing ratio effects typically run both blend orientations plus single-compound controls. Supplied strictly as a laboratory research material.
Peptide class
Synthetic research compound
Mechanism (research context)
Extended mechanistic characterization for this compound is available in the published literature. Consult peer-reviewed references for detailed pathway analysis.
Why it is studied
Ipamorelin / Tesamorelin is studied within its research category (Growth Hormone Research) as a defined-sequence reference compound for laboratory investigation.
Current areas of research
Ghrelin receptor activityGHRH receptor signalingSecretagogue pathway researchPreclinical research
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
Scientific background
Ipamorelin / Tesamorelin is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.
Related
View all →Related research materials
CJC-1295 No DAC / Ipamorelin
5/5 mg
Combined GHRH analog and secretagogue receptor agonist preparation for dual-input pituitary research.
$59.99
DetailsCJC-1295 w/DAC
5 mg
GHRH analog with Drug Affinity Complex modification for extended-duration receptor research.
$79.99
DetailsGHRP-2 Acetate
10 mg
Second-generation growth hormone releasing peptide studied as a ghrelin receptor agonist reference.
$39.99
DetailsIpamorelin / Tesamorelin
5/5 mg · $69.99